Treatment of Severe Cobblestoning in Inflammatory Bowel Disease

Initial Assessment and Treatment Approach

The American Gastroenterological Association indicates that severe cobblestoning in IBD requires immediate corticosteroid initiation, with oral prednisolone 40 mg daily, combined with topical mesalazine as adjunctive therapy, and taper the steroid gradually over 8 weeks once remission is achieved 1
Disease activity should be confirmed by sigmoidoscopy and infection must be excluded before escalating treatment, though corticosteroid therapy should not be delayed while awaiting stool microbiology results, as recommended by the European Crohn’s and Colitis Organisation 2, 1
The presence of severe endoscopic findings like cobblestoning warrants hospitalization if accompanied by systemic symptoms meeting Truelove and Witts' criteria, according to the British Society of Gastroenterology 2

The American College of Gastroenterology recommends starting oral prednisolone 40 mg daily for patients with severe cobblestoning who have not responded to optimized combination therapy with oral mesalazine 2-4 g daily plus topical mesalazine 1 g daily 1
Continue topical mesalazine as adjunctive therapy alongside systemic corticosteroids to maximize local anti-inflammatory effect, as suggested by the European Society for Clinical Nutrition and Metabolism 2, 1
Taper prednisolone gradually over 8 weeks according to clinical response; more rapid reduction is associated with early relapse, according to the American Gastroenterological Association 1

Intravenous fluid and electrolyte replacement to correct dehydration, as recommended by the Society of Critical Care Medicine 2
Daily monitoring of vital signs, stool frequency and character, complete blood count, inflammatory markers, electrolytes, albumin, and liver function tests, according to the American Society of Colon and Rectal Surgeons 2
Daily abdominal radiography if colonic dilatation is detected, as suggested by the European Society of Radiology 2
Joint medical and surgical management with a colorectal surgeon, according to the American Society of Colon and Rectal Surgeons 2

For patients who become steroid-dependent or fail to respond adequately to corticosteroids, the American College of Gastroenterology recommends initiating azathioprine 1.5-2.5 mg/kg/day or mercaptopurine 0.75-1.5 mg/kg/day as steroid-sparing agents 1
Cyclosporine may be effective for severe, steroid-refractory colitis in the acute setting, according to the European Crohn’s and Colitis Organisation 1

Once remission is achieved, lifelong maintenance therapy is generally recommended with aminosalicylates, azathioprine, or mercaptopurine to reduce relapse risk, as suggested by the American Gastroenterological Association 2
Patients should be kept informed that severe endoscopic disease carries a 25-30% chance of eventually requiring surgical intervention, according to the Society of Surgical Oncology 2